Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Prevention

Personalized Nutrition Delivery to Improve Resilience in Older Adult Trauma Patients

Trauma · Critical Illness

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jun 2026
Primary outcome: Primary: Number of Patients Recruited — 28; 12 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Nutrition supplement - Ensure shakes (Dietary_supplement)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients Recruited
28; 12
SECONDARY
Number of Study Participants Who Adhere to the SeND Home Treatment Protocol
28
SECONDARY
Percentage of Participants Retained to Study Completion
75; 67
SECONDARY
Time to Complete Each Outcome
SECONDARY
How Well Outcome Assessments Are Tolerated
SECONDARY
Duration of Testing Time
SECONDARY
Ability to Successfully Complete Testing in One Cycle Will be Recorded
SECONDARY
Provider Satisfaction With SeND Home
SECONDARY
Provider Assessment of Usefulness of SeND Home
SECONDARY
Number of Interventions Delivered Per Protocol in the ICU, on the Floor, and In-home

Summary

This is a Pilot study designed to set up for an randomized clinical trial (RCT) comparing the SeND Home pathway to a standard of care nutrition delivery in critically ill older adult trauma patients. Subjects will be randomized 3:1 to either SeND Home precision nutrition pathway or control arm. Subjects randomized to the SeND Home arm will receive oral nutrition supplements (ONS) up to 3 times per day while in the hospital and for 4 weeks after discharge. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers. Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass.

Eligibility Criteria

Inclusion Criteria

  • Patients who are at least 60 years old and admitted to the trauma service
  • Patients who have had a standard of care CT scan

Exclusion Criteria

  • Expected withdrawal of life-sustaining treatment within 48 hours
  • Prisoners
  • Unable to provide informed consent
  • Non-English speakers
  • Traumatic Brain Injury
  • Allergic to milk or soy ingredients (Common allergen in Ensure shakes).
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05544162). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search